Takeda Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:TKDA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Aug 26	Sell€203,072	Nicola Greenway	Individual	12,980	€15.64
11 Aug 26	Sell€309,697	Elaine Shannon	Individual	20,363	€15.21
10 Aug 26	Sell€524,422	Nicola Greenway	Individual	34,603	€15.16
10 Aug 26	Sell€740,351	Teresa Marie Bitetti	Individual	50,012	€14.80
10 Aug 26	Sell€371,389	Gabriele Ricci	Individual	25,088	€14.80
10 Aug 26	Sell€58,888	Elaine Shannon	Individual	3,978	€14.80
10 Aug 26	Sell€456,954	Natalie Furney	Individual	30,868	€14.80
10 Aug 26	Sell€339,843	Marcello Pignagnoli Agosti	Individual	22,957	€14.80
10 Aug 26	Sell€100,279	Nicola Greenway	Individual	6,774	€14.80
10 Aug 26	Sell€2,448,390	Andrew S. Plump	Individual	165,393	€14.80
10 Aug 26	Sell€460,136	Giles Platford	Individual	31,083	€14.80
10 Aug 26	Sell€1,318,841	Julie Kim	Individual	89,090	€14.80
10 Aug 26	Sell€250,193	Rhonda Pacheco	Individual	16,901	€14.80
10 Aug 26	Sell€704,438	Lauren Duprey	Individual	47,586	€14.80
10 Aug 26	Sell€107,725	Ramy Ibrahim	Individual	7,277	€14.80
10 Aug 26	Sell€207,337	Farajallah Awny Botros	Individual	14,006	€14.80

Insider Trading Volume

Insider Buying: TKDA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TKDA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,000,023	0.125%
General Public	772,993,155	48.4%
Institutions	821,765,561	51.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 42.41% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.61%	BlackRock, Inc.	137,441,978	€4.3b	1.18%	0.05%
4.44%	Nomura Asset Management Co., Ltd.	70,829,800	€2.2b	-7.05%	0.6%
3.86%	Vanguard Capital Management, LLC	61,554,988	€1.9b	0%	0.03%
3.11%	Sumitomo Mitsui Trust Asset Management Co., Ltd.	49,608,663	€1.5b	0%	0.94%
2.9%	Capital Research and Management Company	46,367,395	€1.4b	0.11%	0.06%
2.14%	Amova Asset Management Co., Ltd.	34,232,400	€1.1b	0%	0.33%
2.09%	Daiwa Asset Management Co., Ltd.	33,326,200	€1.0b	0.46%	0.57%
1.55%	Nissay Asset Management Corporation	24,752,000	€768.3m	0%	0.74%
1.41%	Norges Bank Investment Management	22,547,676	€699.9m	0%	0.05%
1.39%	Sumitomo Mitsui Financial Group, Inc.	22,142,000	€687.3m	0%	2.27%
1.26%	JPMorgan Chase & Co.	20,147,885	€625.4m	0.58%	0.08%
1.15%	Mitsubishi UFJ Asset Management Co., Ltd.	18,411,800	€571.5m	-12.6%	0.2%
1.15%	Barclays Bank Plc	18,406,045	€571.4m	0%	0.71%
0.98%	Geode Capital Management, LLC	15,644,514	€485.6m	0.01%	0.03%
0.79%	FMR LLC	12,595,539	€391.0m	-0.35%	0.02%
0.72%	Dimensional Fund Advisors LP	11,477,298	€356.3m	0.18%	0.05%
0.68%	Strategic Advisers LLC	10,929,912	€339.3m	20.6%	0.09%
0.66%	GQG Partners LLC	10,548,100	€327.4m	0%	0.33%
0.61%	T. Rowe Price Group, Inc.	9,709,322	€301.4m	11.2%	0.03%
0.59%	JP Morgan Asset Management	9,385,883	€291.4m	4.74%	0.03%
0.53%	Goldman Sachs Asset Management, L.P.	8,496,733	€263.8m	0.05%	0.05%
0.5%	Deutsche Asset & Wealth Management	8,029,701	€249.3m	0%	0.06%
0.49%	Charles Schwab Investment Management, Inc.	7,768,562	€241.1m	1%	0.03%
0.4%	Vanguard Asset Management, Limited	6,454,985	€200.4m	4.52%	0.07%
0.4%	Amundi Asset Management SAS	6,326,027	€196.4m	0.19%	0.03%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/23 14:36
End of Day Share Price	2026/08/21 00:00
Earnings	2026/06/30
Annual Earnings	2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Takeda Pharmaceutical Company Limited is covered by 29 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Atsushi Seki	Barclays
Miki Sogi	Bernstein
Koichi Mamegano	BofA Global Research